Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALIUSKA ALVAREZ OJEDA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1801878723
CMS profile
1306039
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$3,742.34

187 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALIUSKA ALVAREZ OJEDA

NPI 1801878723 · CMS profile ID 1306039

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801878723?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALIUSKA ALVAREZ OJEDA, NPI 1801878723, CMS profile ID 1306039. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801878723?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ALIUSKA ALVAREZ OJEDA, NPI 1801878723, CMS profile ID 1306039. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801878723?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ALIUSKA ALVAREZ OJEDA, NPI 1801878723, CMS profile ID 1306039, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 187 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1801878723?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

187 matching records · $3,742.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 187 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 187.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $20.7106/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498395 CMS
ABBVIE INC. $7.1606/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498393 CMS
UCB, Inc. $48.1406/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965190019 CMS
IMPEL PHARMACEUTICALS INC. $17.1506/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962305391 CMS
ABBVIE INC. $9.2506/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498391 CMS
Aprecia Pharmaceuticals, LLC $16.5806/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951466773 CMS
GENZYME CORPORATION $15.8606/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938949315 CMS
Neurocrine Biosciences, Inc. $14.5706/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231917 CMS
Neurocrine Biosciences, Inc. $4.4006/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231921 CMS
SK Life Science, Inc. $20.2606/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940700669 CMS
Amneal Pharmaceuticals LLC $13.8906/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572779 CMS
Amneal Pharmaceuticals LLC $124.9706/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572783 CMS
EISAI INC. $3.6806/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908015165 CMS
EISAI INC. $18.3206/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908015169 CMS
UCB, Inc. $49.3105/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965189375 CMS
ABBVIE INC. $22.1805/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498389 CMS
GE HealthCare $21.3905/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953425747 CMS
Neurocrine Biosciences, Inc. $9.0905/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231909 CMS
Neurocrine Biosciences, Inc. $18.5705/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231911 CMS
Neurocrine Biosciences, Inc. $1.7405/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231915 CMS
Biohaven Pharmaceutical Holding Company Ltd. $19.6605/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923525117 CMS
IMPEL PHARMACEUTICALS INC. $20.0005/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962305389 CMS
ABBVIE INC. $8.6205/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498387 CMS
Teva Pharmaceuticals USA, Inc. $24.1605/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954646819 CMS
Amneal Pharmaceuticals LLC $6.2405/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572777 CMS
GENZYME CORPORATION $17.6305/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938949307 CMS
ABBVIE INC. $4.4805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498385 CMS
UCB, Inc. $48.9605/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908123207 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.3604/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923525115 CMS
Biohaven Pharmaceutical Holding Company Ltd. $113.7104/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923525113 CMS
IMPEL PHARMACEUTICALS INC. $2.0404/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962305385 CMS
Lilly USA, LLC $22.6004/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917849715 CMS
Amneal Pharmaceuticals LLC $5.1704/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572773 CMS
EISAI INC. $8.0204/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908015173 CMS
Neurocrine Biosciences, Inc. $19.8904/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231793 CMS
Neurocrine Biosciences, Inc. $4.9704/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231905 CMS
Supernus Pharmaceuticals, Inc. $16.1204/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 952905387 CMS
Amneal Pharmaceuticals LLC $7.8304/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572771 CMS
ABBVIE INC. $19.8204/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498383 CMS
IMPEL PHARMACEUTICALS INC. $20.0004/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962305383 CMS
ABBVIE INC. $5.6904/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890498381 CMS
UCB, Inc. $49.3104/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908123215 CMS
GE HealthCare $19.6604/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953425741 CMS
SK Life Science, Inc. $26.2604/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940700613 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.7603/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923525111 CMS
Lundbeck LLC $31.1103/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945722179 CMS
Neurocrine Biosciences, Inc. $5.5903/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231785 CMS
Neurocrine Biosciences, Inc. $17.7503/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963231791 CMS
Biogen, Inc. $11.8403/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923453851 CMS
Amneal Pharmaceuticals LLC $4.9603/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956572767 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,221.07 131
PY2020 $5,412.93 81
PY2021 $3,994.99 210
PY2022 $3,742.34 187
PY2023 $4,271.58 197
PY2024 $5,095.91 227
PY2025 $4,348.75 166

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $97,360.26 8
PY2024 Principal investigator $742,193.38 82
PY2023 Principal investigator $285,796.92 52
PY2022 Principal investigator $28,799.94 10
PY2021 Principal investigator $54,987.25 6
PY2020 Principal investigator $47,106.25 5
PY2019 Principal investigator $51,192.50 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $77.25 12/31/2025 Non-covered Recipient Entity
IVETMAR MEDICAL GROUP LLC
A Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-552 in Participants with Mild Alzheimer's Disease No dispute reported 06/30/2026 1202532937
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $255.16 07/17/2025 Non-covered Recipient Entity
Elias Research Associates
A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-3) No dispute reported 06/30/2026 1220804460
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $3,250.00 05/16/2025 Non-covered Recipient Entity
Elias Research Associates
A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-3) No dispute reported 06/30/2026 1220804458
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $86,388.00 04/17/2025 Non-covered Recipient Entity
Ivetmar Medical Group Llc
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235996513
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,100.00 04/04/2025 Non-covered Recipient Entity
Advarra
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235999273
Principal investigator 1 ABBVIE INC. $2,000.00 02/27/2025 Non-covered Recipient Entity
IVETMAR MEDICAL GROUP
A Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-552 in Participants with Mild Alzheimer's Disease No dispute reported 06/30/2026 1202455045
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $3,000.00 02/19/2025 Non-covered Recipient Entity
Elias Research Associates
A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-3) No dispute reported 06/30/2026 1220804456
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $289.85 01/27/2025 Non-covered Recipient Entity
Ivetmar Medical Group Llc
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235996515